Role of BAFF in pulmonary autoantibody responses induced by chronic cigarette smoke exposure in mice

Physiol Rep. 2016 Dec;4(24):e13057. doi: 10.14814/phy2.13057.

Abstract

Emerging evidence suggests that autoimmune processes are implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). In this study, we assessed the expression of B-cell activating factor (BAFF) in smokers, and investigated the functional importance of BAFF in the induction and maintenance of cigarette smoke-induced pulmonary antinuclear antibodies (ANA) and tertiary lymphoid tissues (TLTs) using a preclinical mouse model. We observed that BAFF levels were elevated in smokers and mice exposed to cigarette smoke. In mice, BAFF expression was rapidly induced in the lungs following 4 days of cigarette smoke exposure and remained elevated following 8 and 24 weeks of exposure. Alveolar macrophages were the major source of BAFF Blockade of BAFF using a BAFF receptor-Fc (BAFFR-Fc) construct prevented pulmonary ANA and TLT formation when delivered concurrent with cigarette smoke exposure. Under these conditions, no impact on lung inflammation was observed. However, administration of BAFFR-Fc following smoking cessation markedly reduced the number of TLTs and ANA levels and, of note, reduced pulmonary neutrophilia. Altogether, this study shows for the first time a central role of BAFF in the induction and maintenance of cigarette smoke-induced pulmonary ANA and suggests that BAFF blockade following smoking cessation could have beneficial effects on persistent inflammatory processes.In this study, we assessed the expression of B-cell activating factor (BAFF) in smokers, and investigated the functional importance of BAFF in the induction and maintenance of cigarette smoke-induced pulmonary antinuclear antibodies (ANA) and tertiary lymphoid tissues (TLTs) using a preclinical mouse model. Data presented show that BAFF plays a central role in the induction and maintenance of cigarette smoke-induced pulmonary ANA and suggest a therapeutic potential for BAFF blockade in limiting autoimmune processes associated with smoking.

Keywords: BAFF; COPD; Animal model; autoantibodies; cigarette smoke.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Antinuclear / metabolism*
  • B-Cell Activating Factor / immunology*
  • B-Cell Activating Factor / metabolism
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / metabolism
  • Cigarette Smoking / adverse effects*
  • Female
  • Humans
  • Immunoglobulin M / metabolism
  • Lung / drug effects*
  • Lung / immunology*
  • Lung / metabolism
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Middle Aged
  • Nicotiana / adverse effects*
  • Smoking Cessation
  • Spleen / drug effects
  • Spleen / metabolism
  • Tertiary Lymphoid Structures / chemically induced
  • Tertiary Lymphoid Structures / immunology

Substances

  • Antibodies, Antinuclear
  • B-Cell Activating Factor
  • Immunoglobulin M
  • TNFSF13B protein, human
  • Tnfsf13b protein, mouse